Treatment with tunicamycin (TM), an N-glycosylation inhibitor, in combination with gemcitabine significantly reduces the viability of PANC-1 cells, suggesting that targeting the N-glycosylation pathway holds promise for combination therapy in PDAC [157]
10.1038/s41418-019-0380-z 228 WangS.LiX.LiJ.WangA.LiF.HuH.et al (2024)
Transitions to Type I collagen at a faster rate in BPC-157-treated tissue, improving the long-term tensile quality of the repair
The NACIAM trial, a study carried out in Adelaide, revealed that early initiation of high-dose intravenous NAC in patients with myocardial infarctions (in addition to regular treatment protocols) results in significantly smaller sizes of dead heart tissue ( 10 )
"Questions and answers about autism spectrum disorders (ASD)"
A complete health history is required before any protocol is initiated